|11/17/14||Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference|
|BELGRADE, Mont., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the Singular Research 9th Annual Best of the Uncovereds Conference, to be held November 20, 2014 at the Westin in New York at Times Square. Bacterin's presentation will take place Thursday, November 20, 2014 at 10:30am ET.
|11/14/14||Bacterin Receives Delisting Notice From NYSE MKT|
|BELGRADE, Mont., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE) today announced that the Company received notice that the staff of NYSE Regulation, Inc. has determined to commence proceedings to delist the Company's common stock from the NYSE MKT LLC ("NYSE MKT" or the "Exchange") because the Company did not cure its non-compliance with Sections 1003(a)(i), (ii) and (iii) of the NYSE MKT Company Guide by the end of the maximum 18 month compliance plan per... |
|11/11/14||Bacterin CEO Dan Goldberger to be Guest on FOX Business Network's After the Bell with Liz Claman|
|BELGRADE, Mont., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE:BONE) today announced its CEO Dan Goldberger will be a guest on FOX Business Network's After the Bell with Liz Claman at approximately 4:15 PM/ET on Tuesday, November 11, 2014. Bacterin is a medical device company and accredited tissue bank that designs, processes, manufactures, and markets advanced medical products.
During the show, Mr. Goldberger is expected to talk about the company's growth opp... |
|11/05/14||Bacterin Announces Third Quarter 2014 Results|
|Company Increases Year-Over-Year Sales, Improves Margins and Reduces Loss From Operations
Third Quarter Highlights:
Third Quarter 2014 total revenue increased approximately 6.6% to $8.454 million from $7.930 million reported during the third quarter of 2013
Gross profit increased 17.9% to $5.436 million compared to $4.612 million reported during the third quarter of 2013
Gross margins improved to 64.3%, an increase from 58.2% reported in the third quarter of 2013